Journal Rank: CiteScore 3.2 - Q3 (Oncology)
Submission to first decision: 55 days

Journal of Cancer Metastasis and Treatment

On June 9, 2025, the editorial team had the great honor of interviewing a pioneer in ovarian cancer research - Prof. Robert C. Bast fromThe University of Texas MD Anderson Cancer Center.
The aim of the current study was to review recent advances and provide an overview of current therapeutic approaches for patients with NELM.
Read it NOW!
On March 20, 2025, the Journal of Cancer Metastasis and Treatment (JCMT) has been officially included in the Chinese Academy of Sciences (CAS) Journal Ranking system.
The 10th iteration of the Congress brings together international experts in oncology, immunobiology, pharmacology, molecular biology, and molecular imaging to discuss preclinical, translational, and clinical advances in diagnosing, treating and preventing cancer metastasis.
To celebrate this milestone, we have organized a series of special content and events to commemorate JCMT's decade of advancing cancer research.

Exclusive Interview with Prof. Robert C. Bast: A Pioneer in Ovarian Cancer Research

NaN

Coming soon.

Journal of Cancer Metastasis and Treatment
ISSN 2454-2857 (Online) 2394-4722 (Print)

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/